Journal article

Reactive oxygen species and Alzheimer's disease.

G Multhaup, T Ruppert, A Schlicksupp, L Hesse, D Beher, CL Masters, K Beyreuther

Biochemical Pharmacology | Published : 1997

Abstract

Although a consensus that Alzheimer's disease (AD) is a single disease has not been reached yet, the involvement of the amyloid precursor protein (APP) and betaA4 (A beta) in the pathologic changes advances our understanding of the underlying molecular alterations. Increasing evidence implicates oxidative stress in the neurodegenerative process of AD. This hypothesis is based on the toxicity of betaA4 in cell cultures, and the findings that aggregation of betaA4 can be induced by metal-catalyzed oxidation and that free oxygen radicals may be involved in APP metabolism. Another neurological disorder, familial amyotrophic lateral sclerosis (FALS), supports our view that AD and FALS may be link..

View full abstract